ReachRxResearch
Home
Research
Sign Up
Robotic vs Thoracolaparoscopic Esophagectomy for Esophageal Cancer
Back to Research Hub
  1. Home
  2. Research Hub
  3. Robotic vs Thoracolaparoscopic Esophagec…

Robotic vs Thoracolaparoscopic Esophagectomy for Esophageal Cancer

JAMA Surgery·September 30Open Access
SurgeryPractice changingEsophageal AdenocarcinomaEsophagogastric Junction AdenocarcinomaRandomized Controlled TrialMinimally Invasive SurgeryRobotic SurgeryAdultOlder Adult

Summary

View source

What was studied

This phase 3 RCT compared robot-assisted minimally invasive esophagectomy (RAMIE) vs conventional minimally invasive esophagectomy (MIE) in 202 patients with resectable esophageal or esophagogastric junction adenocarcinoma (cT1-4a, cN0-3, cM0) across 4 high-volume centers in Europe (2021–2025), with follow-up up to 5 years.

Key findings

RAMIE yielded a significantly higher median lymph node count than MIE (36 vs 32; P = .005), with comparable R0 resection rates (99.0% vs 97.0%), similar postoperative complication rates, low 90-day mortality (1.0% vs 3.0%; P = .62), and no difference in 1-year survival.

Study limitations

The trial was conducted at 4 high-volume tertiary referral centers, which may limit generalizability to lower-volume settings; follow-up survival data beyond 1 year are not yet mature; and the clinical significance of the 4-node difference in lymph node yield on long-term oncological outcomes remains to be established.

Clinical implications

RAMIE achieves a more extensive lymphadenectomy than conventional MIE without added surgical risk, supporting its use as a standard approach for esophageal and esophagogastric junction adenocarcinoma in centers with robotic expertise.

Caveats

  • All 4 centers were high-volume tertiary referral centers; outcomes may not reflect results in lower-volume or community hospital settings
  • The 4-node difference in median lymph node yield, while statistically significant, has unknown clinical impact on long-term survival; oncological superiority of RAMIE is not yet proven
  • The study population was 89.6% male, limiting generalizability to female patients with esophageal adenocarcinoma

Related Questions

Explore related topics

Does a higher lymph node yield from esophagectomy improve long-term survival in esophageal adenocarcinoma?Robotic versus laparoscopic esophagectomy: complication rates and oncological outcomes comparedOptimal lymph node count targets in transthoracic esophagectomy for esophagogastric junction cancer

Publication Details

Year
2026
Journal
JAMA Surgery
Sample Size
n=202
Source
View article
Keep scrolling
More content below.
Up Next